{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:49:04Z","timestamp":1783403344383,"version":"3.54.6"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction\/objectives<\/jats:title>\n                    <jats:p>Axial spondyloarthritis (axSpA) is a heterogeneous disease with variable clinical features changing over the disease course, making diagnosis and monitoring challenging. Large progress has been made in classification development, imaging, disease-activity assessment. However, there is limited insight in how these developments are addressed in daily clinical practice. Therefore, our study aim was to gain better insight into diagnosis, monitoring and treatment and to explore if non-radiographic (nr-)axSpA is addressed differently from radiographic (r-)axSpA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multiple-choice survey on diagnosis, monitoring, and treatment of axSpA was conducted in semi-structured, face-to-face interviews with 51 Dutch rheumatologists, representing a range of geographical locations, hospital types, and axSpA expertise.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of all participating rheumatologists, 78% worked in secondary referral centers, reflecting Dutch rheumatology practice. 52% felt insufficiently skilled to independently assess MRI sacroiliitis. Diagnostic uncertainty was higher for nr-axSpA (23%) than r-axSpA (10%). ASAS classification criteria were used to diagnose nr- and r-axSpA by 54% and 36% of rheumatologists. For monitoring disease activity, ASDAS was always or never used by 28% and 26% of rheumatologists. In treatment decisions concerning biological DMARDs, the level of pain was considered equally important as disease activity scores (ASDAS, BASDAI). Most rheumatologists (60%) did not use ASDAS or BASDAI cut-off scores or change to evaluate biological DMARDs\u2019 effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study reveals that Dutch rheumatologists experienced difficulties in diagnosing axSpA in one out of four patients. ASAS classification criteria were often used for support, particularly in diagnosing nr-axSpA. The use of disease-activity assessments during monitoring was limited.<\/jats:p>\n                    <jats:p>\n                      <jats:table-wrap>\n                        <jats:table>\n                          <jats:tbody>\n                            <jats:tr>\n                              <jats:td align=\"left\" colspan=\"2\">\n                                <jats:bold>Key Points<\/jats:bold>\n                                \u2022\n                                <jats:italic>Diagnostic uncertainty remains common in daily practice, particularly for non-radiographic axial spondyloarthritis.<\/jats:italic>\n                                \u2022\n                                <jats:italic>Although ASAS classification criteria were developed for research purposes, they are also used to support diagnosis.<\/jats:italic>\n                                \u2022\n                                <jats:italic>ASDAS is used inconsistently to monitor disease activity and many rheumatologists seem to base treatment decisions on reported pain level.<\/jats:italic>\n                                \u2022\n                                <jats:italic>There seems to be a gap between axial spondyloarthritis international management recommendations and routine rheumatology care.<\/jats:italic>\n                              <\/jats:td>\n                            <\/jats:tr>\n                          <\/jats:tbody>\n                        <\/jats:table>\n                      <\/jats:table-wrap>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10067-026-08157-0","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:36:18Z","timestamp":1778722578000},"page":"4265-4276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Challenges in diagnosing and monitoring radiographic and non-radiographic axial spondyloarthritis in daily clinical practice"],"prefix":"10.1007","volume":"45","author":[{"given":"Anneke","family":"Spoorenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6809-6799","authenticated-orcid":false,"given":"Yvonne Maria","family":"van der Kraan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"de Hair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Arends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"12","key":"8157_CR1","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/annrheumdis-2021-221035","volume":"80","author":"V Navarro-Comp\u00e1n","year":"2021","unstructured":"Navarro-Comp\u00e1n V, Sepriano A, El-Zorkany B, van der Heijde D (2021) Axial spondyloarthritis. Ann Rheum Dis 80(12):1511\u20131521","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8157_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"LS Van Der","year":"1984","unstructured":"Van Der LS, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum 27(4):361\u2013368","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8157_CR3","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/art.20990","volume":"52","author":"M Rudwaleit","year":"2005","unstructured":"Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria? Arthritis Rheum 52(4):1000\u20131008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8157_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13075-019-1927-6","volume":"21","author":"C L\u00f3pez-Medina","year":"2019","unstructured":"L\u00f3pez-Medina C, Dougados M, Ruyssen-Witrand A, Molt\u00f3 A (2019) Evaluation of concomitant peripheral arthritis in patients with recent onset axial spondyloarthritis: 5-year results from the DESIR cohort. Arthritis Res Ther 21(1):139","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"8157_CR5","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/ard.2009.108217","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Landew\u00e9 R, van der Heijde D, Listing J, Brandt J, Braun J et al (2009) The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68(6):770\u2013776","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8157_CR6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Listing J, Akkoc N, Brandt J et al (2009) The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777\u2013783","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8157_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3899\/jrheum.130959","volume":"42","author":"J Braun","year":"2015","unstructured":"Braun J, Baraliakos X, Kiltz U, Heldmann F, Sieper J (2015) Classification and diagnosis of axial spondyloarthritis \u2014 What is the clinically relevant difference? J Rheumatol 42(1):31\u201338","journal-title":"J Rheumatol"},{"issue":"10473","key":"8157_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0140-6736(24)02263-3","volume":"405","author":"V Navarro-Comp\u00e1n","year":"2025","unstructured":"Navarro-Comp\u00e1n V, Sepriano A, Capelusnik D, Baraliakos X (2025) Axial spondyloarthritis. The Lancet 405(10473):159\u2013172","journal-title":"The Lancet"},{"issue":"12","key":"8157_CR9","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286\u20132291","journal-title":"J Rheumatol"},{"issue":"1","key":"8157_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/ard.2008.094870","volume":"68","author":"C Lukas","year":"2009","unstructured":"Lukas C, Landew\u00e9 R, Sieper J, Dougados M, Davis J, Braun J et al (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68(1):18\u201324","journal-title":"Ann Rheum Dis"},{"key":"8157_CR11","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68:ii1-44","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"8157_CR12","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1136\/annrheumdis-2018-213184","volume":"77","author":"PM Machado","year":"2018","unstructured":"Machado PM, Landew\u00e9 R, van der Heijde D (2018) Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states. Ann Rheum Dis 77(10):1539\u20131540","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8157_CR13","first-page":"980","volume":"26","author":"A Spoorenberg","year":"1999","unstructured":"Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26(4):980\u2013984","journal-title":"J Rheumatol"},{"issue":"1","key":"8157_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X et al (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82(1):19\u201334","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8157_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/annrheumdis-2012-203201","volume":"73","author":"J Sieper","year":"2014","unstructured":"Sieper J, Lenaerts J, Wollenhaupt J, Rudwaleit M, Mazurov VI, Myasoutova L et al (2014) Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1. Ann Rheum Dis 73(1):101\u2013107","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"8157_CR16","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1002\/art.39257","volume":"67","author":"J Sieper","year":"2015","unstructured":"Sieper J, van der Heijde D, Dougados M, Maksymowych WP, Scott BB, Boice JA et al (2015) A Randomized, Double-Blind, Placebo-Controlled, Sixteen-Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis. Arthritis & Rheumatology 67(10):2702\u20132712","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"8157_CR17","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Ramiro S, Landew\u00e9 R, Baraliakos X, Van den Bosch F, Sepriano A et al (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978\u2013991","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8157_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210656","volume":"76","author":"RB Landew\u00e9","year":"2017","unstructured":"Landew\u00e9 RB, van der Heijde DM (2017) Why CAPS criteria are not diagnostic criteria? Ann Rheum Dis 76(4):e7","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"8157_CR19","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1136\/annrheumdis-2016-210747","volume":"76","author":"A Sepriano","year":"2017","unstructured":"Sepriano A, Rubio R, Ramiro S, Landew\u00e9 R, van der Heijde D (2017) Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis. Ann Rheum Dis 76(5):886\u2013890","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8157_CR20","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-208642","volume":"75","author":"RGW Lambert","year":"2016","unstructured":"Lambert RGW, Bakker PAC, van der Heijde D, Weber U, Rudwaleit M, Hermann KGA et al (2016) Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Ann Rheum Dis 75(11):1958\u20131963","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8157_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41584-019-0309-4","volume":"15","author":"WP Maksymowych","year":"2019","unstructured":"Maksymowych WP (2019) The role of imaging in the diagnosis and management of axial spondyloarthritis. Nat Rev Rheumatol 15(11):657\u2013672","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"8157_CR22","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/art.40475","volume":"70","author":"J de Winter","year":"2018","unstructured":"de Winter J, de Hooge M, van de Sande M, de Jong H, van Hoeven L, de Koning A et al (2018) Magnetic Resonance Imaging of the Sacroiliac Joints Indicating Sacroiliitis According to the Assessment of SpondyloArthritis international Society Definition in Healthy Individuals, Runners, and Women With Postpartum Back Pain. Arthritis & Rheumatology 70(7):1042\u20131048","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"8157_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000586","volume":"4","author":"C Lukas","year":"2018","unstructured":"Lukas C, Cyteval C, Dougados M, Weber U (2018) MRI for diagnosis of axial spondyloarthritis: major advance with critical limitations \u2018Not everything that glisters is gold (standard).\u2019 RMD Open 4(1):e000586","journal-title":"RMD Open"},{"issue":"3","key":"8157_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/annrheumdis-2020-216999","volume":"80","author":"RBM Landew\u00e9","year":"2021","unstructured":"Landew\u00e9 RBM, van der Heijde D (2021) Use of multidimensional composite scores in rheumatology: parsimony versus subtlety. Ann Rheum Dis 80(3):280\u2013285","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"8157_CR25","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D van der Heijde","year":"2009","unstructured":"van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J et al (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68(12):1811\u20131818","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"8157_CR26","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1136\/annrheumdis-2014-205178","volume":"73","author":"S Ramiro","year":"2014","unstructured":"Ramiro S, van der Heijde D, van Tubergen A, Stolwijk C, Dougados M, van den Bosch F et al (2014) Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis 73(8):1455\u20131461","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"8157_CR27","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1136\/annrheumdis-2016-209209","volume":"75","author":"D Poddubnyy","year":"2016","unstructured":"Poddubnyy D, Protopopov M, Haibel H, Braun J, Rudwaleit M, Sieper J (2016) High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort. Ann Rheum Dis 75(12):2114\u20132118","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8157_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/rheumatology\/keaa564","volume":"60","author":"A Sepriano","year":"2021","unstructured":"Sepriano A, Ramiro S, Wichuk S, Chiowchanwisawakit P, Paschke J, van der Heijde D et al (2021) Disease activity is associated with spinal radiographic progression in axial spondyloarthritis independently of exposure to tumour necrosis factor inhibitors. Rheumatology 60(1):461\u2013462","journal-title":"Rheumatology"},{"issue":"1","key":"8157_CR29","first-page":"61","volume":"35","author":"S Arends","year":"2017","unstructured":"Arends S, Brouwer E, Efde M, van der Veer E, Bootsma H, Wink F et al (2017) Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice. Clin Exp Rheumatol 35(1):61\u201368","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"8157_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004528","volume":"10","author":"YM van der Kraan","year":"2024","unstructured":"van der Kraan YM, Paap D, Timmerman H, Wink F, Arends S, Reneman M et al (2024) Value of the central sensitisation inventory in patients with axial spondyloarthritis. RMD Open 10(4):e004528","journal-title":"RMD Open"},{"key":"8157_CR31","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1093\/rheumatology\/keaf102","volume":"64","author":"SC Kieskamp","year":"2025","unstructured":"Kieskamp SC, van der Kraan Y, Arends S, Wink F, Bos R, Stewart R et al (2025) Interrelationships of disease activity, central sensitization, psychosocial and lifestyle factors in axial spondyloarthritis. Rheumatology 64:3547\u20133555","journal-title":"Rheumatology"},{"issue":"10","key":"8157_CR32","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1093\/rheumatology\/keab019","volume":"60","author":"SC Kieskamp","year":"2021","unstructured":"Kieskamp SC, Paap D, Carbo MJG, Wink F, Bos R, Bootsma H et al (2021) Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis. Rheumatology 60(10):4476\u20134485","journal-title":"Rheumatology"},{"issue":"1","key":"8157_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/annrheumdis-2017-212178","volume":"77","author":"A Molto","year":"2018","unstructured":"Molto A, Gossec L, Meghnathi B, Landew\u00e9 RBM, van der Heijde D, Atagunduz P et al (2018) An assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in Axial Spondyloarthritis based on ASDAS. Ann Rheum Dis 77(1):124\u2013127","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"8157_CR34","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s40744-023-00585-7","volume":"10","author":"YM van der Kraan","year":"2023","unstructured":"van der Kraan YM, Paap D, Lennips N, Veenstra ECA, Wink FR, Kieskamp SC et al (2023) Patients\u2019 needs concerning patient education in axial spondyloarthritis: a qualitative study. Rheumatol Ther 10(5):1349\u20131368","journal-title":"Rheumatol Ther"},{"issue":"10","key":"8157_CR35","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/art.41042","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA et al (2019) 2019 update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network recommendations for the treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol 71(10):1599\u20131613","journal-title":"Arthritis Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08157-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08157-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08157-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:27:30Z","timestamp":1783398450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08157-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["8157"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08157-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"8 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}